COVID-19 vaccination has no link to sudden deaths in young adults: ICMR-NIE
'Past COVID hospitalisation, a family history of sudden death, and certain lifestyle behaviours increased the likelihood of sudden deaths [in young adults],' Dr. Murhekar said, adding that research had, in fact, indicated the positive effect of vaccination.
There was no urgency or need for the reintroduction of the COVID-19 vaccine as a booster dose now, Dr. Murhekar said. 'As of now, we aren't seeing any major spikes in COVID cases, and there are no trends indicating the need for booster doses. We also know that newer variants are escaping vaccination cover so we need not rush into getting booster doses as of now,' he said.
Baseless linking of COVID-19 vaccination to sudden deaths could hamper the vaccination programmes for other diseases, he cautioned. 'It is easy to blame vaccination without any scientific basis but the negative impact it has on the overall acceptance and adherence to vaccination trial participations and use suffers,' Dr. Murhekar said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
43 minutes ago
- News18
If Vaccines Hadn't Saved Us From Covid-19, We Wouldn't Be Here To Question Heart Attacks
Last Updated: There is no conclusive proof that Covid vaccines directly caused a spike in heart attacks but we can't ignore that Covid-19 itself has left behind a legacy of cardiovascular damage The rise in heart-related complications and sudden deaths post-Covid-19 has triggered several debates, especially around the role of vaccines. Social media amplifies claims—often anecdotal, rarely scientific—linking Covid-19 vaccines to cardiac issues. But here's a fundamental question: If these vaccines hadn't been developed in record time, would we have even lived long enough to speculate on their side effects? The latest debate was triggered by a post on the social media platform X, where Karnataka's Chief Minister Siddaramaiah wrote on July 1: 'In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously… It cannot be denied that the hasty approval and distribution of the Covid vaccine to the public could also be a reason for these deaths, as several studies worldwide have recently indicated that COVID vaccines could be a cause for the increasing number of heart attacks…" In response, what we saw throughout last week was a coordinated and deliberate effort from the Centre, leading medical institutions, and vaccine manufacturers to rebuild and reinforce public confidence in Covid-19 vaccines. Siddaramaiah's claim was strongly rebutted, not only by government-run institutions but also by top pharmaceutical executives, researchers, and well-known doctors. Sample this: The Indian Pharmaceutical Alliance (IPA)—the lobby of domestic pharmaceutical companies representing Sun Pharma, Glenmark, Lupin, Cipla and many others—issued a strong statement supporting Covid-19 vaccines. Industry leaders like Kiran Mazumdar-Shaw of Biocon and Samir Mehta of Torrent Pharma also publicly backed vaccine safety and dismissed the unfounded claims. Top doctors from AIIMS and scientists at ICMR have taken to public platforms to bust myths and explain the science, stressing that panic must not replace facts. The Serum Institute of India (SII)—manufacturer of India's poster boy vaccine Covishield—also reaffirmed that Covid-19 vaccines are safe, scientifically validated, and critical in saving lives. Given that over 170 crore doses of Covishield have been administered out of the 200+ crore total vaccine doses in India, this clarification is not just welcome but vital. These clarifications were essential in addressing the growing public anxiety around sudden cardiac deaths, particularly among younger people. While these incidents are tragic and deserve a detailed investigation, the Union government has made it unequivocally clear: these deaths should not be automatically linked to Covid-19 vaccination. Let's understand this scientifically. As of today, there is no conclusive evidence that Covid-19 vaccines directly caused a spike in heart attacks or sudden cardiac arrests in India. However, we must not ignore a crucial truth: Covid-19 itself has left behind a legacy of cardiovascular damage. The virus is known to inflame blood vessels and affect heart muscle tissue. A 2022 study in Nature Medicine found a 63 per cent higher risk of heart attack in patients within a year of Covid infection. Multiple global studies, including those published in respected medical journals such as The Lancet and the New England Journal of Medicine, have shown that the risk of myocarditis and other heart complications is higher after a Covid-19 infection than after vaccination. A study conducted by the Indian Journal of Medical Research—a peer-reviewed publication supported by ICMR—concluded that Covid-19 vaccination was not associated with an increased risk of unexplained sudden death among young adults. On the contrary, the study documented that vaccination reduced the risk of unexplained sudden death in this age group. The Indian Council of Medical Research (ICMR) and the National Technical Advisory Group on Immunisation (NTAGI) have reiterated that adverse events following immunisation (AEFIs) remain extremely rare. India's official AEFI data shows less than 0.01 per cent serious reactions among the more than 2.2 billion doses administered. Add to this another critical factor: Indians are more genetically susceptible to heart diseases than Western populations. According to a Lancet Regional Health Southeast Asia study published in February 2023, the cardiovascular burden in India is higher than the global average. The age-standardised death rate globally is 233 deaths per 1,00,000, while for India it is 282 per 1,00,000. Yet, unfounded narratives continue to gain traction—some fuelled by misinformation, others by genuine grief seeking answers in a complex post-pandemic landscape. What the available evidence shows is that vaccines, by reducing the severity and spread of the virus, likely played a role in limiting long-term cardiovascular consequences. They weren't just about immediate survival—they bought us time and prevented the invisible wave of complications that continues to unfold. Even if science someday finds a small causal link between certain vaccines and rare cardiac events, we must remember: public health is about trade-offs. During a pandemic, decisions must be made under pressure, aiming to save as many lives as possible. Vaccines were not perfect and they were never claimed to be. What they were, and remain, is effective and life-saving on a population scale. It's also essential to acknowledge the wider ecosystem of risk: lockdown-induced sedentary lifestyles, elevated stress, mental health challenges, and delayed chronic care. And also, the genetic structure of Indians, which is vulnerable to metabolic resistance, hence, diabetes and cardiovascular diseases develop relatively easily. These all contribute to rising cardiac cases—and must be part of the conversation. Blaming vaccines alone oversimplifies a deeply layered issue. top videos View all In short, this is not a defence of pharmaceutical companies or vaccine makers who profited heavily during the pandemic, nor is it a dismissal of the real grief of those who lost loved ones. This is a call for nuance. We need to look at the full picture, not just one side of the story. Let's continue investigating, let's strengthen pharmacovigilance and monitoring across India. Remember, we are alive to debate the side effects because the vaccines worked. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : AIIMS COVID-19 vaccine covishield health matters Kiran Mazumdar-Shaw news18 specials Serum Institute of India Siddaramaiah Location : New Delhi, India, India First Published: July 07, 2025, 10:00 IST News india If Vaccines Hadn't Saved Us From Covid-19, We Wouldn't Be Here To Question Heart Attacks
Hindustan Times
an hour ago
- Hindustan Times
Covid cases decline in Pune after brief rise in May
After a slight surge in Covid-19 cases in May, Pune city reported a decline in numbers in the month of June, Pune Municipal Corporation (PMC) officials said. However, the situation improved in June, with the number of cases decreasing to 68, they said. (FILE) According to PMC officials, in May, the city reported 93 Covid cases, a significant increase after months of very low activity. However, the situation improved in June, with the number of cases decreasing to 68, they said. Furthermore, from January to April this year, Pune had reported just one COVID-19 case, indicating almost no presence of virus circulation in the city during that period. The rise in May was not serious and was handled well due to ongoing health surveillance and prompt response measures, said the civic health officials. 'The increase in May was minor, and there is no reason for concern at this time. Many cases tested positive in private city hospitals were incorrectly reported to be from the PMC limits. We are continuing our surveillance to ensure early detection and control,' said Dr Vaishali Jadhav, assistant health officer, PMC. PMC authorities have urged citizens to stay alert, maintain hygiene, and consult doctors if they experience symptoms. People should avoid panic and instead focus on being cautious, especially people in high-risk categories. Besides, vaccination, timely testing, and responsible behaviour are still important in keeping COVID-19 under control, they said. As per the statement issued by the Public Health Department, on Sunday Maharashtra reported 8 fresh COVID-19 cases. Of which, 2 are from PMC, 5 are from Mumbai and 1 from Kolhapur. Since January 2025, as many as 2577 covid cases and 41 deaths amongst the infected have been reported. Also, the state has a recovery rate of 95.92%. Besides, since January, as many as 2569 covid cases and 41 deaths amongst the infected have been reported. Furthermore, currently, there are 64 active Covid cases in the state. Since January, Mumbai has reported 1012 covid cases, of which the highest 551 cases were reported in June alone, said Dr Sandeep Sangale, joint director of Health Services. Dr Sangale said the number of cases have declined in the state. 'The team is conducting regular surveillance of influenza-like illness (ILI) and severe acute respiratory syndrome (SARI) patients. Around 5% of ILI patients and all SARI patients are tested for COVID-19. Besides, samples of all positive patients are sent for Whole Genome Sequencing.'
Time of India
4 hours ago
- Time of India
Tech professors turn startup founders, VCs take note
ETtech Academy Empower your mind, elevate your skills For years, India's leading research institutions engaged in cutting-edge research and development, much of which remained confined to labs. That's beginning to change as faculty members are turning entrepreneurs, and investors are taking Indian Institute of Science (IISc), Indian Institutes of Technology (IITs), Indian Institutes of Information Technology (IIITs) and BITS Pilani, professor-founded startups have seen a 20-30% year-onyear increase. Venture capitalists (VCs) are viewing these ventures as fertile ground for intellectual property (IP)-heavy, globally competitive deep tech innovation 'We've invested in about eight or nine professor-led startups across our two funds from IITs, IISc and even global institutions like MIT, Harvard and Caltech. It's not yet the norm, but it's definitely a growing pattern,' said Ashwin Raghuraman, co-founder of Bharat Innovation Fund, an early-stage venture told ET that earlier, professors faced peer pressure and felt they were 'selling out' by focusing on commercialisation, caught in the classic 'Lakshmi versus Saraswati", or wealth versus knowledge, dilemma. But that mindset is now starting to change. 'With founders now raising series B and C in deep tech, it's giving academics more confidence that this isn't just an experiment, it can scale,' said Manu Iyer, co-founder of BlueHill watchers said success stories such as Ather Energy , where IIT Madras' incubation centre earned Rs 50 crore, and other startups, such as Agnikul Cosmos, ePlane and Pure EV, scaling up are prompting more professors to consider entrepreneurship.'Simply writing papers wasn't satisfying because the traditional way by which science is taken forward isn't inclusive. It started to feel more attractive to explore something on the entrepreneurial side,' said Manoj Gopalkrishnan, founder of Algorithmic who served as a professor at IIT Bombay for more than a decade, launched the molecular diagnostics startup in 2021 after his Covid-19-related research paper went viral and drew VC interest. Satya Chakravarthy, professor of aerospace engineering from IIT Madras, has co-founded six deep tech Invest, which has invested in six professor-led startups, said incubation centres are playing a big role. They provide a framework for professors and startups to collaborate, encouraging faculty entrepreneurship, and professors are seen as people who know their domains inside out.'Today's professors, especially those in their 40s and 50s, are incredibly well-informed. They've seenthe practical side of business and understand the soul of their technology. For deep tech startups, they often make the best founders,' said Rajaram
